<!DOCTYPE html>
<html>
<head>
<title>Carbetocin Guideline for PPH in Caesarean Birth</title>
</head>
<body>
<h1>Carbetocin Guideline for PPH in Caesarean Birth</h1>

<h2>Purpose</h2>
<p>These guidelines are for the use of Carbetocin to prevent postpartum haemorrhage (PPH) in caesarean birth. Carbetocin is recommended for use in specialist obstetric units by experienced staff.</p>

<h2>Eligibility</h2>
<p>Carbetocin should be offered to all patients undergoing caesarean birth unless contraindicated.</p>

<h2>Administration</h2>
<p>Carbetocin must only be given after the birth of the baby and as soon as possible after umbilical cord clamping. The dose is 100â€¯micrograms to be given over 1 minute, diluted with 0.9% sodium chloride.</p>

<h2>Contraindications</h2>
<ul>
<li>Pregnancy and labour before birth of the baby</li>
<li>Hypersensitivity to Carbetocin or oxytocin</li>
<li>Hepatic or renal disease</li>
<li>Serious cardiovascular disorders</li>
<li>Epilepsy</li>
<li>Severe eclampsia or pre-eclampsia</li>
</ul>

<h2>Cautions</h2>
<ul>
<li>Cardiovascular disease</li>
<li>Severe hypotension</li>
<li>Hyponatraemia or water intoxication</li>
<li>Pre-eclampsia or eclampsia</li>
<li>General anaesthesia</li>
<li>Migraine</li>
<li>Asthma</li>
</ul>

<h2>Additional Information</h2>
<p>If uterine tone remains inadequate following administration of 100mcgs, a 2nd line agent should be considered. Carbetocin should be used cautiously in patients with migraine, asthma, and cardiovascular disease. Interactions with other drugs have not been identified, but cannot be excluded due to its structural similarity to oxytocin.</p>

<h2>Adverse Effects</h2>
<ul>
<li>Anaemia</li>
<li>Headache</li>
<li>Tremor</li>
<li>Nausea</li>
<li>Hypotension</li>
<li>Flushing</li>
<li>Chest pain</li>
<li>Dyspnoea</li>
<li>Pruritis</li>
<li>Back pain</li>
<li>General discomfort</li>
</ul>

<h2>Monitoring and Review</h2>
<p>Monitoring and review of compliance with guidelines and review of incident cases are necessary.</p>

</body>
</html>